$138.23
0.740.54%
At Close: -
$138.23
00.00%
After Hours: 1:08 PM EDT
15 minutes delayed
Neurocrine Biosciences
NBIXNASDAQ
Neurocrine Biosciences (NASDAQ:NBIX) Stock, Earnings Estimates, EPS, And Revenue
Neurocrine Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 30
EPS Estimate
$1.030
Quarterly Revenue Estimate
$546.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2B
Analyze the earnings history of Neurocrine Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences | $1.25 | $1.03 | — | — | $452.70M | $546.85M | — | — | 07/30/2024 | Get Alert |
| NBIX | Neurocrine Biosciences | -$0.51 | $1.01 | $1.20 | 18.81% | $420.40M | $511.97M | $515.30M | 0.65% | 05/01/2024 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.24 | $1.15 | $1.54 | 33.91% | $412.00M | $518.13M | $515.20M | -0.57% | 02/07/2024 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.08 | $0.98 | $1.54 | 57.14% | $387.90M | $469.92M | $498.80M | 6.15% | 10/31/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.84 | $0.77 | $1.25 | 62.34% | $378.20M | $448.89M | $452.70M | 0.85% | 08/01/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.30 | $0.13 | -$0.51 | -492.31% | $310.60M | $409.35M | $420.40M | 2.70% | 05/03/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.04 | $1.14 | $1.24 | 8.77% | $312.00M | $409.09M | $412.00M | 0.71% | 02/06/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.64 | $0.80 | $1.08 | 35.00% | $296.00M | $376.50M | $387.90M | 3.03% | 11/01/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.63 | $0.59 | $0.84 | 42.37% | $288.90M | $341.31M | $378.20M | 10.81% | 08/04/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.49 | $0.34 | $0.30 | -11.76% | $236.60M | $303.40M | $310.60M | 2.37% | 05/04/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.91 | $0.52 | $0.04 | -92.31% | $247.90M | $316.79M | $312.00M | -1.51% | 02/11/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.97 | $0.60 | $0.64 | 6.67% | $258.50M | $297.65M | $296.00M | -0.55% | 11/01/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.42 | $0.49 | $0.63 | 28.57% | $302.40M | $274.38M | $288.90M | 5.29% | 08/03/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.82 | $0.51 | $0.49 | -3.92% | $237.10M | $250.63M | $236.60M | -5.60% | 05/05/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.05 | $0.54 | $0.91 | 68.52% | $244.10M | $262.40M | $247.90M | -5.53% | 02/04/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.90 | $0.22 | $0.97 | 340.91% | $222.09M | $283.04M | $258.50M | -8.67% | 11/09/2020 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.71 | $0.73 | $1.42 | 94.52% | $183.58M | $260.34M | $302.40M | 16.16% | 08/03/2020 | Get Alert |
| NBIX | Neurocrine Biosciences | -$1.12 | $0.54 | $0.82 | 51.85% | $138.40M | $223.87M | $237.10M | 5.91% | 05/06/2020 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.19 | $0.75 | $1.05 | 40.00% | $131.49M | $230.94M | $244.10M | 5.70% | 02/04/2020 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.52 | $0.64 | $0.56 | -12.50% | $151.76M | $211.63M | $222.09M | 4.94% | 11/04/2019 | Get Alert |
| NBIX | Neurocrine Biosciences | -$0.07 | $0.11 | $0.32 | 190.91% | $96.91M | $163.14M | $183.58M | 12.53% | 07/29/2019 | Get Alert |
Neurocrine Biosciences (NBIX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-01 | $1.20 | $1.01 | 18.8 % |
| Dec 2023 | 2024-02-07 | $1.54 | $1.15 | 33.9 % |
| Sep 2023 | 2023-10-31 | $1.54 | $0.98 | 57.1 % |
| Jun 2023 | 2023-08-01 | $1.25 | $0.77 | 62.3 % |
Neurocrine Biosciences (NBIX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-01 | $515.30M | $511.97M | 0.65 % |
| Dec 2023 | 2024-02-07 | $515.20M | $518.13M | -0.57 % |
| Sep 2023 | 2023-10-31 | $498.80M | $469.92M | 6.15 % |
| Jun 2023 | 2023-08-01 | $452.70M | $448.89M | 0.85 % |
FAQ
When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?
Neurocrine Biosciences (NBIX) is scheduled to report earnings on July 30, 2024. The last reported earnings were for reported on May 1, 2024 for Q1.
What were the latest earnings per share (EPS) for Neurocrine Biosciences (NASDAQ:NBIX)?
The Actual EPS was $1.20, which beat the estimate of $1.01.
What were Neurocrine Biosciences’s (NASDAQ:NBIX) revenues?
The Actual Revenue was $515.3M, which beat the estimate of $512M.
Browse earnings estimates, EPS, and revenue on all stocks.